Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy

Hongyu Zhang, Jharna Saha, Jaeman Byun, Mary Lee Schin, Matthew Lorenz, Robert T. Kennedy, Matthias Kretzler, Eva L. Feldman, Subramaniam Pennathur, Frank C. Brosius

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Fingerprint

Dive into the research topics of 'Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy'. Together they form a unique fingerprint.

Medicine & Life Sciences